MedEquities Realty Trust Initiated with a Buy at Cantor Fitzgerald

By Ryan Adsit

Cantor Fitzgerald analyst Joseph France initiated coverage with a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $14. The company’s shares opened today at $11.46.

France noted:

“Post-acute care focus. MRT is focused primarily on skilled nursing, inpatient rehabilitation facilities and long-term acute care hospitals. The company’s focus was developed and is guided by senior management, which, combined, has more than 80 years of experience evaluating, lending to, and investing in, post-acute care services.”

According to, France is a 5-star analyst with an average return of 11.1% and a 53.0% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and WellCare Health Plans.

Currently, the analyst consensus on MedEquities Realty Trust is Strong Buy and the average price target is $13.67, representing a 19.3% upside.

In a report issued on August 24, KeyBanc also reiterated a Buy rating on the stock with a $13 price target.

Based on MedEquities Realty Trust’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $14.59 million and quarterly net profit of $4.72 million. In comparison, last year the company earned revenue of $6.59 million and had a GAAP net loss of $865K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MedEquities Realty Trust, Inc. operates as a real estate investment trust. It focuses on investment in healthcare properties and healthcare related real estate debt investments. It owns, develops, operates, leases, and disposes healthcare properties and portfolios. The company was founded in April 23, 2014 and is headquartered in Nashville, TN.